ECSP982394A - ARILSULFONYLAMINOHYDROXAMIC ACID DERIVATIVES - Google Patents
ARILSULFONYLAMINOHYDROXAMIC ACID DERIVATIVESInfo
- Publication number
- ECSP982394A ECSP982394A ECSP982394A ECSP982394A EC SP982394 A ECSP982394 A EC SP982394A EC SP982394 A ECSP982394 A EC SP982394A EC SP982394 A ECSP982394 A EC SP982394A
- Authority
- EC
- Ecuador
- Prior art keywords
- acid derivatives
- matrix metalloproteinase
- arilsulfonylaminohydroxamic
- present
- production
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 2
- 102000002274 Matrix Metalloproteinases Human genes 0.000 abstract 2
- 108010000684 Matrix Metalloproteinases Proteins 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 1
- 206010053177 Epidermolysis Diseases 0.000 abstract 1
- 208000031481 Pathologic Constriction Diseases 0.000 abstract 1
- 206010039705 Scleritis Diseases 0.000 abstract 1
- 206010040047 Sepsis Diseases 0.000 abstract 1
- 206010040070 Septic Shock Diseases 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000002648 combination therapy Methods 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract 1
- 208000028169 periodontal disease Diseases 0.000 abstract 1
- 230000036303 septic shock Effects 0.000 abstract 1
- 230000036262 stenosis Effects 0.000 abstract 1
- 208000037804 stenosis Diseases 0.000 abstract 1
- 230000006433 tumor necrosis factor production Effects 0.000 abstract 1
- 230000036269 ulceration Effects 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere a derivados de ácidos arilsulfonilaminohidroxámicos que son inhibidores de metaloproteinasa matriciales o de la producción de factor de mecrosis tumoral (TNF) y, como tales, son útiles en el tratamiento de una condición seleccionada del grupo formado por artritis, cáncer, ulceración de tejidos, estenosis, enfermedad periodontal, epidermolises ampollosa, escleritis y otras enfermedades caracterizadas por actividad metaloproteinasas matriciales, SIDA, sepsis, shock séptico y otras enfermedades que implican la producción de TNF. Además, los compuestos de la presente invención se puede usar en terapia combinada con fármacos antiinflamatorios no esteroideos.The present invention relates to arylsulfonylaminohydroxamic acid derivatives that are inhibitors of matrix metalloproteinase or tumor mecrosis factor (TNF) production and, as such, are useful in the treatment of a condition selected from the group consisting of arthritis, cancer, tissue ulceration, stenosis, periodontal disease, epidermolyses bullosa, scleritis, and other diseases characterized by matrix metalloproteinase activity, AIDS, sepsis, septic shock, and other diseases involving TNF production. Furthermore, the compounds of the present invention can be used in combination therapy with non-steroidal anti-inflammatory drugs.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982394 ECSP982394A (en) | 1998-02-03 | 1998-02-03 | ARILSULFONYLAMINOHYDROXAMIC ACID DERIVATIVES |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982394 ECSP982394A (en) | 1998-02-03 | 1998-02-03 | ARILSULFONYLAMINOHYDROXAMIC ACID DERIVATIVES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP982394A true ECSP982394A (en) | 1998-12-29 |
Family
ID=42043317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP982394 ECSP982394A (en) | 1998-02-03 | 1998-02-03 | ARILSULFONYLAMINOHYDROXAMIC ACID DERIVATIVES |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP982394A (en) |
-
1998
- 1998-02-03 EC ECSP982394 patent/ECSP982394A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GT199800025A (en) | ARILSULFONYLAMINOHYDROXAMIC ACID DERIVATIVES. | |
| AR009292A1 (en) | DERIVATIVES OF ACID ARILSULFONILAMINO HIDROXAMICO, PROCESSES FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT | |
| PA8446101A1 (en) | ARILSULFONIL HYDROXAMIC ACID DERIVATIVES | |
| EA199900036A1 (en) | METALLIC PROTEASIS INHIBITORS OF MATRIX ON THE BASIS OF PHOSPHINATES, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT | |
| PA8444201A1 (en) | CYCLE DERIVATIVES OF SULFONA | |
| CY1108292T1 (en) | DMXAA ANTI-CANCER CONTAINER | |
| ES2153031T3 (en) | ARILSULFONIL HYDROXAMIC ACID DERIVATIVES AS INHIBITORS OF MMP AND TNF. | |
| ECSP034568A (en) | PIRIMIDIN 2,4,6-TRIONA TYPE METALOPROTEINASE INHIBITORS | |
| BG108450A (en) | Aromatic dicarboxylic acid derivatives | |
| AR003935A1 (en) | COMPOUND DERIVED FROM ACID ARILSULFONILAMINO HIDROXAMICO, PHARMACEUTICAL COMPOSITION THAT CONTAINS IT AND METHOD FOR ITS PREPARATION. | |
| ES2178724T3 (en) | ARILSULFONAMIDE ALPHA-SUBSTITUTED HYDROXAMIC ACIDS AS INHIBITORS OF ALFA TUMOR NECROSIS FACTOR AND MATRIX METALOPROTEINASES. | |
| DE60312715D1 (en) | USE OF THE QUINAZOLINE DERIVATOR ZD6474 COMBINED WITH GEMCITABIN AND, IF APPLICABLE, IONIZING RADIATION FOR THE TREATMENT OF CANCER | |
| UY28081A1 (en) | COMBINED ADMINISTRACINN OF AN INDOLINONE WITH A CHEMOTHERAPCUTIC AGENT FOR CELL PROLIFERACINN DISORDERS | |
| PT1153024E (en) | 2-AMINO-6-ANILINE PURINS AND THEIR USE AS MEDICINES | |
| ECSP066421A (en) | MODULATION OF THE EXPRESSION OF eIF4E | |
| UY27169A1 (en) | DERIVATIVES OF THE ISOFTALIC ACID AS INHIBITORS OF METALPROTEINASES OF THE MATRIX | |
| BR9908084A (en) | Compound, process to treat a patient afflicted by a disorder of the central and peripheral nervous system, pharmaceutical composition, and use of a compound | |
| UY25992A1 (en) | PROCEDURE FOR PREPARING TACE INHIBITORS (TUMOR NECROSIS ALPHA FACTOR CONVERSING ENZYME) | |
| NO20071426L (en) | Cancer combination therapy including AZD2171 and Imatinib | |
| ES2194779T3 (en) | 1-AMINOTRIAZOLO (4,3-A) QUINAZOLIN-5-ONAS AND / OR 5-PHOSPHODIESTERASE INHIBITING TIONAS IV. | |
| CR6860A (en) | NEW INHIBITING DIBENZOAZULENE COMPOUNDS OF THE TUMOR NECROSIS FACTOR | |
| DE69912432D1 (en) | USEFUL FOR THE TREATMENT OF CANCER THIOPHEN- AND FURAN-2,5-DICARBOXAMIDES | |
| NO20082566L (en) | Combination of AZ2171 and permetrexed | |
| DE60311788D1 (en) | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | |
| ECSP982394A (en) | ARILSULFONYLAMINOHYDROXAMIC ACID DERIVATIVES |